Nanoscale drug-delivery capsules that release their therapeutic cargo when triggered by a temperature change could boost the efficacy and reduce the side effects of many drugs.
Researchers at RIKEN have combined lipids and peptides to create capsules with temperature-responsive controlled release behavior (Journal of the American Chemical Society, “Spontaneous formation of gating lipid domain in uniform-size peptide vesicles for controlled release”). The hybrid capsules combine the advantages of each material to enhance both capsule stability and controlled release.
Although many experimental drug-delivery capsules, or ‘vesicles’, have been developed recently, several hurdles still have to be overcome before they can be widely used in the real world, explains Motoki Ueda from the RIKEN Center for Emergent Matter Science, who co-led the study alongside Yoshihiro Ito.
“Some of the problems that still need to be solved include low stability, short circulation times in the bloodstream, controlled drug release and poor targeting of tissue,” Ueda says. “I’m convinced that soft materials can overcome these problems.”
Lipid assemblies are soft materials that have many advantages as drug-delivery vesicles, including the ability to self-assemble, biocompatibility, biodegradation, phase transitions at useful temperatures and the ability to fuse to cell membranes. But vesicles made purely from lipids are too fragile to withstand for long the physical stresses encountered when traveling through the bloodstream.
Now, Ito, Ueda and their colleagues have created high-stability, drug-delivery vesicles by combining lipids with peptides—another soft material that has the ability to self-assemble. The hybrid vesicles consisted mainly of a tough peptide material interspersed with small patches of lipid.
“The peptide-rich areas make the hybrid vesicles highly stable,” says Ueda. The hybrid vesicles are more stable than lipid vesicles, retaining their shape and structural integrity when stored for a month at 4 degrees Celsius. “On the other hand, the lipid domain underwent a phase change from gel to liquid crystal.”
Image Credit: Alfred Pasieka
News This Week
Nature wades through the literature on the new coronavirus — and summarizes key papers as they appear: 1 June — Positive coronavirus test is no guarantee of infectiousness People with COVID-19 are unlikely to [...]
In April, blood clots emerged as one of the many mysterious symptoms attributed to Covid-19, a disease that had initially been thought to largely affect the lungs in the form of pneumonia. Quickly after came [...]
Scientists from the University of Maryland School of Medicine (UMSOM) developed an experimental diagnostic test for COVID-19 that can visually detect the presence of the virus in 10 minutes. It uses a simple assay [...]
Rheumatologists at the University of Alberta are flagging similarities between the deaths of some COVID-19 patients and those with rheumatic illnesses, and are testing proven rheumatic treatments to see whether they help against [...]
Next-gen nano technologies that can prevent infection and diagnose disease are set to transform the medical industry as this important UniSA research is awarded more than $2 million dollars under the National Health and [...]
In late December last year, Dr. Li Wenliang began warning officials about a novel coronavirus in Wuhan, China, but was silenced by the police before tragically succumbing to the disease two months later. Meanwhile, [...]
Almost 10 weeks into the pandemic, COVID-19 is continuing to surprise and baffle health experts. In fact, experts' picture of exactly how COVID-19 might play out in the body is now quite different to [...]
EPFL scientists have developed a new computational approach to create artificial proteins, which showed promising results in vivo as functional vaccines. This approach opens the possibility to engineer safer and more effective vaccines. Vaccines [...]
A group of tiny RNA that should attack the virus causing COVID-19 when it tries to infect the body are diminished with age and chronic health problems, a decrease that likely helps explain why [...]
Purple rashes, swollen legs, clogged catheters and sudden death — blood clots, large and small, are a frequent complication of COVID-19, and researchers are just beginning to untangle why. For weeks, reports have poured [...]
Coronavirus vaccine trials are underway around the world. China’s hoping it can be first for ‘redemption’
In a medical centre in the eastern city of Xuzhou, a few dozen healthy adults have become some of the first to trial a vaccine candidate for the coronavirus. They are among a small [...]
A team of researchers hailing from Harvard and Université de Montréal today launched Epitopes.world, an AI-powered, interactive platform designed to facilitate COVID-19 vaccine development. It’s built atop an algorithm — CAMAP — that generates predictions for potential [...]
The "Human Brain/Cloud Interface" paper had more views that 99% of Frontiers articles. It has now been added to Frontier's "Nanotechnologies in Neuroscience and Neuroengineering" ebook which is available for download. Contributors: Frank J. [...]
This is the full-length version of this post. You can read the condensed version, which appeared as an opinion article in the Washington Post, here. The coronavirus pandemic pits all of humanity against the virus. The [...]
European photonics scientists are developing an ultrasensitive laser sensor that detects coronavirus at the earliest point of infection from a saliva or nasal swab in minutes. Responding to the European Commission’s Express Calls to [...]
Understanding how COVID-19 attacks the human body is essential to developing an effective treatment or vaccine to stop the global pandemic — but there's still so much we don't know about how it can kill us. As [...]